Clinical Trial Update: An Open Label Prostate Cancer Study in Japanese Patients [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial of a prostate cancer therapy in Japanese patients, sponsored by AstraZeneca, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Investigational prostate cancer therapy (AstraZeneca)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED